まとめ
研究者らは,TGF-β1とは異なる,血小板内の成長因子β (TGF-β2) を変容させる新しい形態を発見した. これらのTGF-β変種は,細胞受容体と異なる相互作用を行い,細胞増殖と組織調節に影響を与えます.
科学分野:
- 分子生物学は分子生物学である.
- 細胞生物学 細胞生物学
- バイオケミストリー バイオケミストリー
背景:
- 変形成長因子β (TGFβ) は,細胞の成長と分化を調節する上で重要な役割を果たします.
- 血小板は,TGF-βを含む様々な成長因子を蓄え,放出することが知られている.
研究 の 目的:
- 豚の血小板におけるTGF-βの新しい形態を特定し,特徴づけること.
- 細胞表面受容体とTGF-βイソフォームの異なる相互作用を調査する.
- これらの相互作用が細胞の調節に及ぼす影響を理解する.
主な方法:
- 生化学技術を用いた豚の血小板からのTGF-βイソフォームの分離と特徴付け.
- 異なるTGF-β形態に対する受容体結合親和性の分析,放射性リガンド測定を用いて.
- 細胞増殖の阻害などの細胞応答との受容体占有率の相関.
主要な成果:
- 血小板における既知のTGF-β1と共に,新しいホモディマー形態であるTGF-β2の識別.
- TGF-β1とTGF-β2の両方の鎖からなるヘテロダイマー,TGF-β1.2の分離.
- 異なる結合親和性が観察された: 280 kDa の受容体はTGF-β1とTGF-β2の両方に高い親和性で結合し, 65 kDa と 85 kDa の受容体はTGF-β1に対してTGF-β2よりも高い親和性を示している.
- 細胞増殖の抑制は,TGF-β1またはTGF-β2による280 kDaの受容体占有率と相関する.
結論:
- 血小板に特異なTGF-βイソフォーム (TGF-β1とTGF-β2) とそのヘテロダイマー (TGF-β1.2) が存在していること.
- 異なる受容体相互作用は,TGF-β信号の微調整のためのメカニズムを提供します.
- この分子柔軟性は,TGF-βシステムによる組織成長と分化の微妙な調節を可能にします.
さらに関連する動画
11:38Visualization and Quantification of TGFβ/BMP/SMAD Signaling under Different Fluid Shear Stress Conditions using Proximity-Ligation-Assay
Published on: September 14, 2021
2.4K
06:57Analysis of Transforming Growth Factor ß Family Cleavage Products Secreted Into the Blastocoele of Xenopus laevis Embryos
Published on: July 21, 2021
1.3K
関連する概念動画
Interactions Between Signaling Pathways
4.7K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
4.7K
Receptor Tyrosine Kinases
15.7K
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
15.7K
TGF - β Signaling Pathway
7.2K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K
Signal Transduction: Overview
8.6K
Cells respond to many types of information, often through receptor proteins positioned on the membrane. They respond to chemical signals, such as hormones, neurotransmitters, and other signaling molecules, initiating a series of molecular reactions to produce an appropriate response. This is called signal transduction. Cells also coordinate different responses elicited by the same signaling molecule via mediators, allowing molecular cross-talk.
Typically, signal transduction involves three...
Typically, signal transduction involves three...
8.6K
Transducer Mechanism: G Protein–Coupled Receptors
9.1K
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
GPCRs are also called heptahelical,...
9.1K
Transducer Mechanism: Enzyme-Linked Receptors
4.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
4.4K
